Andrew Lu
Boston University(US)Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Cancer-related Molecular Pathways, Advanced biosensing and bioanalysis techniques, Cancer Cells and Metastasis, Angiogenesis and VEGF in Cancer
Most-Cited Works
- → Myelin Activates FAK/Akt/NF-κB Pathways and Provokes CR3-Dependent Inflammatory Response in Murine System(2010)123 cited
- → A histone deacetylase 3–dependent pathway delimits peripheral myelin growth and functional regeneration(2018)96 cited
- → pH dependent transfer of nano-pores into membrane of cancer cells to induce apoptosis(2013)51 cited
- → Targeting SRC Coactivators Blocks the Tumor-Initiating Capacity of Cancer Stem-like Cells(2017)42 cited
- → PHLPP1 mediates melanoma metastasis suppression through repressing AKT2 activation(2018)38 cited
- → p16 Modulates VEGF Expression via Its Interaction With HIF-1α in Breast Cancer Cells(2010)36 cited
- Suppression of breast cancer metastasis through the inhibition of VEGF-mediated tumor angiogenesis.(2007)
- → HIF-1α Promotes A Hypoxia-Independent Cell Migration(2010)20 cited
- → Development of a Novel Anti-HIF-1α Screening System Coupled with Biochemical and Biological Validation for Rapidly Selecting Potent Anti-Cancer Compounds(2014)5 cited
- Targeted Delivery of Nano-pores into Cancer Cells Using pHLIP® Coated Liposomes(2021)